Systematic review for evaluation of tolerability of nonsteroidal antiinflammatory drugs in osteoarthritis patients in Japan

Journal of Orthopaedic Science

Volumn 8, Issue 3, 2003, Pages 279-287

  Uemura, Shinichi ^a,e   Ochi, Takahiro ^b   Sugano, Kentaro ^c   Makuch, Robert W ^d  

^a JUNTENDO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d YALE UNIVERSITY   (United States)

^e NONE   (Japan)

Author keywords

Meta analysis; Nonsteroidal antiinflammatory drugs (NSAIDs); Osteoarthritis; Systematic review; Tolerability

Indexed keywords

ACEMETACIN; ALMINOPROFEN; AMFENAC; ANTHRANILIC ACID; CARBOXYLIC ACID; DICLOFENAC; ETODOLAC; FENBUFEN; FENOPROFEN CALCIUM; IBUPROFEN; INDOLEACETIC ACID; INDOMETACIN; KETOPROFEN; LOXOPROFEN; MELOXICAM; MOFEZOLAC; NABUMETONE; NAPHTHALENE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PHENYLACETIC ACID DERIVATIVE; PIROXICAM; PROGLUMETACIN MALEATE; PROPIONIC ACID; SALICYLIC ACID; TIAPROFENIC ACID; TOLFENAMIC ACID; TOLMETIN; UNINDEXED DRUG; ZALTOPROFEN;

ABDOMINAL PAIN; ANOREXIA; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HUMAN; INCIDENCE; INTESTINE PERFORATION; JAPAN; NAUSEA; OSTEOARTHRITIS; PEPTIC ULCER BLEEDING; REVIEW; RISK ASSESSMENT; SEX RATIO; STOMATITIS; ULCER; VOMITING;

EID: 0038120882     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10776-002-0631-6     Document Type: Review

References (58)

1. Aoki T, Kamano T, Kawamura J, et al. Double blind, control, comparative study of fenbufen in the treatment of osteoarthritis of the knee. J Clin Exp Med 1977;103:110-26 (in Japanese).
2. Amako T, Yamamoto S, Aritomi H. Double blind clinical trial of fenbufen against diclofenac at the multicenter for the treatment of osteoarthritis in the knee. Jpn J Clin Pharmacol Ther 1982;13: 425-32 (in Japanese).
3. Aoki T, Sugawara S, Hoshino T, et al. Clinical evaluation of CS-600 (loxoprofen sodium) on osteoarthritis of the knee - a multicenter, double blind, controlled trial in comparison with diclofenac sodium. J Clin Exp Med 1986;136:983-1001 (in Japanese).
4. Aoki T, Murota K, Yabe Y, et al. Clinical evaluation of RPY-001 in the treatment of osteoarthritis of the knee - a multicenter, double blind, controlled trial in comparison with piroxicam. Jpn Pharmacol Ther 1989;17:3329-45 (in Japanese).
5. Aoki T, Ohi S, Kawaji W, et al. Clinical evaluation of SR-318 on osteoarthritis of knee joint - double blind comparative study with diclofenac sodium tablets. Clin Rep 1990;24:5545-57 (in Japanese).
6. Aoki T, Kawaji W, Kuroki Y, et al. Clinical evaluation of RAK291 on osteoarthritis of the knee: double blind study in comparison with indomethacin. J Clin Ther Med 1991;7:1543-63 (in Japanese).
7. Aoki T, Kawaji W, Kuroki Y, et al. Efficacy assessment of nabumetone on osteoarthritis of the knee. J New Rem Clin 1991;40:2422-39 (in Japanese).
8. Aoki T, Kaneda K, Sakurai M, et al. A phase III study of UHAC62 (meloxicam) capsule in osteoarthritis of the knee joint. J Clin Ther Med 1997; 13:973-1013 (in Japanese).
9. Aoki T, Kuroki Y, Sugawara S, et al. Clinical evaluation TS110 for osteoarthritis: multicenter double blind comparative study using diclofenac sodium as control. Jpn J Inflamm 1997;1:195-214 (in Japanese).
10. Aritomi H, Kageyama T, Sugawara S, et al. Clinical evaluation of EB-382 (alminoprofen) in the treatment of osteoarthritis of the knee - a double blind comparative study. Clin Eval 1986;14:723- 56 (in Japanese).
11. Aritomi H, Ogawa S, Azuma I. Clinical evaluation of CN-100 in the treatment of osteoarthritis of the knee. Ryumachi 1991;31: 112-26 (in Japanese).
12. Bensen WG, Zhao SZ, Burke TA, et al. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo. J Rheumatol 2000;27:1876-83.
13. Dequeker J, Hawkey C, Kahan A, et al. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the safety and efficacy large-scale evaluation of COX-inhibiting therapies (SELECT) trial in osteoarthritis. Br J Rheumatol 1998;37:946-51.
14. Ehsanullah RS, Page MC, Tildesley G, et al. Prevention of gastroduodenal damage induced by non-steroidal antiinflammatory drugs: controlled trial of ranitidine. BMJ 1998; 297:1017-21.
15. Ekström P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal antiinflammatory drug therapy: a Nordic multicentre study. Scand J Gastroenterol 1996; 338:727-34.
16. Enas GG, Goldstein DJ. Defining, monitoring and combining safety information in clinical trials. Stat Med 1995;14:1099-111.
17. Fairweather WR. Integrated safety analysis: statistical issues in the assessment of safety in clinical trials. Drug Inf J 1996;30:875-79.
18. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs: a meta-analysis. Ann Intern Med 1991;115: 787-96.
19. Guslandi M. Epidemiological aspects of NSAID gastropathy. Ital J Gastroenterol 1996;28:6-8.
20. Hawkey CJ, Karrasch JA, SzczepanskiL L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998;338:727-34.
21. Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual nonsteroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-6.
22. Hirohata K, Ishikawa S, Ohno O, et al. Clinical evaluation of oxaprozin in the treatment of osteoarthritis of the knee: a multicenter, double blind, controlled study in comparison with indomethacin. J Clin Exp Med 1984;130:164-78 (in Japanese).
23. Huang JQ, Sridhar S, Hunt RH. Gastrointestinal safety profile of nabumetone: a meta-analysis. Am J Med 1999;107:55S-64S.
24. Igarashi M, Hayashi Y, Masuda M, et al. Clinical evaluation of pranoprofen on osteoarthritis of the knee: a multi-center, double blind comparative study compared to indomethacin and placebo. J Clin Exp Med 1979;119:188-211 (in Japanese).
25. Igarashi M, Iwao T, Inoue H, et al. Clinical evaluation of tolmetin sodium on osteoarthritis of the knee: double blind comparative study. Clin Rep 1980;14:2611-25 (in Japanese).
26. Imura M, Koga Y, Nakano M, et al. Clinical evaluation of GEA6414 on osteoarthritis of the knee by double blind comparative study. Clin Rep 1981;15:929-69 (in Japanese).
27. Kageyama T, Sugawara S, Aoki T, et al. Clinical evaluation of sulindac in the treatment of osteoarthritis of the knee: a double blind, controlled study in comparison with diclofenac Na. Jpn Pharmacol Ther 1979;7:761-81 (in Japanese).
28. Kageyama T, Aoki T, Kawaji W, et al. Clinical evaluation of tiaprofenic acid: a double blind, controlled study in comparison with indomethacin in the treatment of osteoarthritis of the knee. Jpn J Clin Exp Med 1981;58:2327-38 (in Japanese).
29. Kageyama T, Aritomi H, Kawaji W, et al. Clinical evaluation of the effect of fenoprofen calcium against osteoarthritis of the knee: double blind comparative trial. Clin Eval 1981;9:435-60 (in Japanese).
30. Kageyama T, Rikimaru Y, Aoki T, et al. Clinical evaluation of piroxicam in the treatment of osteoarthritis of the knee: a double blind, controlled study in comparison with indomethacin. J Adult Dis 1981;6:927-40 (in Japanese).
31. Kageyama T, Aoki T, Fujita E, et al. Efficacy evaluation of amfenac sodium (AHR-5850) in the treatment of osteoarthritis of the knee. Clin Rep 1982;16:6719-40 (in Japanese).
32. Kageyama T, Sugano T, Yamamoto M, et al. Clinical evaluation of diflunisal in the treatment of osteoarthritis of the knee. Clin Eval 1983;11:461-87 (in Japanese).
33. Kageyama T, Aoki T, Igarashi M, et al. Clinical evaluation of pirprofen on osteoarthritis of the knee: a double blind comparative study. Jpn Pharmacol Ther 1985;13:1011-32 (in Japanese).
34. Kageyama T, Wakamatsu H, Mikage K, et al. Clinical evaluation of tenoxicam on osteoarthritis of the knee: double blind study. Jpn Pharmacol Ther 1985;13:3085-102 (in Japanese).
35. 2 receptor antagonist, ranitidine, for NSAID induced gastro-duodenal damage. J Adult Dis 1990;20:253-64 (in Japanese).
36. Komatsubara Y, Ogawa R, Tanaka K, et al. Clinical evaluation of nabumetone in the treatment if osteoarthritis of the knee. Clin Rep 1988;22:2343-55 (in Japanese).
37. Langman MJ. Epidemiology of non-steroidal anti-inflammatory drug damage to stomach and duodenum. Ital J Gastroenterol Hepatol 1999;31:S2-5.
38. Langman MJ, Jensen DM, Watson DJ, et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999;282:1929-33.
39. Lee MT, Lazarus R. Meta-analysis of drug safety data with logistic regression. Drug Inf J 1997;31:1189-93.
40. Mikage K, Aoki T, Sugano T, et al. Clinical evaluation of proglumetacin maleate for geniculum osteoarthritis: multicenter double blind test using diclofenac sodium as a controlled drug. Jpn Pharmacol Ther 1986;14:6557-76 (in Japanese).
41. Nagaya I, Moriya H, Matsui N, et al. Clinical evaluation of mofezolac in osteoarthritis of the knee: a double blind trial comparative study using indomethacin as control drug. Clin Rep 1990;24:6473-86 (in Japanese).
42. Riedemann PJ, Bersinic S, Cuddy LJ, et al. A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a meta-analysis. J Rheumatol 1993;20:2095-103.
43. Saito T, Hasegawa M. NSAID induced gastrointestinal toxicity: survey for RA patients of Japan Rheumatism Friendship Association. Ryumachi 2001;41:375 (in Japanese).
44. Schoenfeld P. Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials. Am J Med 1999;107:48S-54S.
45. Shibano K, Takahashi H, Ando K, et al. Clinical evaluation of tolfenamic acid on osteoarthritis of the knee: a double blind comparative study. Clin Rep 1980;14:1468-79 (in Japanese).
46. Shichikawa K, Komatsubara R, Kimura M, et al. Clinical effects of acemetacin (K-708) for osteoarthritis of the knee: a double blind clinical study in comparison with indomethacin. Jpn Pharmacol Ther 1981;9:5079-99 (in Japanese).
47. Shimazu A, Hirohashi K, Asada K, et al. Efficacy evaluation of K708 in the treatment of osteoarthritis of the knee. Jpn Pharmacol Ther 1981;9:2855-72 (in Japanese).
48. Shiokawa Y, Nobunaga M, Saito T, et al. Epidemiology study on upper gastrointestinal lesions induced by non-steroidal antiinflammatory drugs. Ryumachi 1991;31:554-71 (in Japanese).
49. Shiokawa Y, Nobunaga M, Saito T, et al. Evaluation of misoprostol's clinical utility for gastric/duodenal ulcers seen under long-term use of non-steroidal anti-inflammatory drugs (NSAID). I. Evaluation of mucosal prophylactic effects by a placebo-controlled double blind comparative study, Ryumachi 1991;31:554-71 (in Japanese).
50. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA 2000;284:1247-55.
51. Singh G, Ramey DR. NSAID-induced gastrointestinal complications: the ARAMIS perspective - 1997. J Rheumatol 1998; 25:8-16.
52. Spencer-Green G, Spencer-Green E. Nonstroidal therapy of rheumatoid arthritis and osteoarthritis: how physicians manage treatment failures. J Rheumatol 1998;25:2088-93.
53. Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused non-steroidal anti-inflammatory drugs. N Engl J Med 1996;334:1435-39.
54. Towheed TE, Hochberg MC. A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the hip. J Rheumatol 1997;24:349-57.
55. Wakamatsu E, Funayama K, Kobayashi S, et al. Clinical trial of fenbufen in the treatment if osteoarthritis of the knee. Jpn J Clin Exp Med 1982;59:3127-34 (in Japanese).
56. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999;340: 1888-99.
57. Yamamoto M, Kawaji W, Miura Y, et al. Clinical evaluation of E-0710 on osteoarthritis: a double blind study in comparison with indomethacin. Jpn Pharmacol Ther 1989;17:2277-301 (in Japanese).
58. Yamanaka H, Singh G, Matsuda Y. Planning of J-ARAMIS for RA patients in Japan. Ryumachi 2001;41:521 (in Japanese).